Study on the role of environmental parameters and HIF-1A gene polymorphism in coronary collateral formation among patients with ischemic heart disease

Clinical Biochemistry

Volumn 44, Issue 17-18, 2011, Pages 1421-1424

  Alidoosti, Mohammad ^a   Ghaedi, Mahboobeh ^b   Soleimani, Abbas ^a   Bakhtiyari, Salar ^c   Rezvanfard, Mehrnaz ^a   Golkhu, Shekufeh ^d   Mohammadtaghvaei, Narges ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ALZAHRA UNIVERSITY   (Iran)

^e AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary collateral formation; Hypoxia inducible factor 1 (HIF 1); Iranian population; Polymorphism

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTEINE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HYPOXIA INDUCIBLE FACTOR 1; LOW DENSITY LIPOPROTEIN; THREONINE; VASCULOTROPIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; CORONARY VESSEL OBSTRUCTION; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEART MUSCLE ISCHEMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SUBSTITUTION REACTION;

AGED; AMINO ACID SUBSTITUTION; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 81555205783     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.09.001     Document Type: Article

References (40)

1. Fukai M., Ii M., Nakakoji T., Kawakatsu M., Nariyama J., Yokota N., et al. Angiographically demonstrated coronary collaterals predict residual viable myocardium in patients with chronic myocardial infarction: a regional metabolic study. J Cardiol 2000, 35(2):103.
2. Sabia P.J., Powers E.R., Ragosta M., Sarembock I.J., Burwell L.R., Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992, 327(26):1825-1831.
3. Grobbee D.E. Future perspectives in atherosclerosis research: an epidemiologic view. Progression and regression of atherosclerosis 1995, 478-482. Blackwell Scientific Publications, Vienna.
4. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986, 314(8):488-500.
5. Koerselman J., van der Graaf Y., de Jaegere P.P.T., Grobbee D.E. Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 2003, 107(19):2507.
6. Oliver M.F. Prevention of coronary heart disease-propaganda, promises, problems, and prospects. Circulation 1986, 73(1):1.
7. Chittenden T.W., Sherman J.A., Xiong F., Hall A.E., Lanahan A.A., Taylor J.M., et al. Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation 2006, 114(17):1811.
8. Rivard A., Fabre J.E., Silver M., Chen D., Murohara T., Kearney M., et al. Age-dependent impairment of angiogenesis. Circulation 1999, 99(1):111.
9. Rivard A., Berthou-Soulie L., Principe N., Kearney M., Curry C., Branellec D., et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 2000, 275(38):29643.
10. Fujita M., Otsuka K.I., Nakae I., Ueda K., Tamaki S.I., Kihara Y., et al. Determinants of collateral development in patients with acute myocardial infarction. Clin Cardiol 1999, 22(9):595-599.
11. Heinle R.A., Levy R.I., Gorlin R. Effects of factors predisposing to atherosclerosis on formation of coronary collateral vessels. Am J Cardiol 1974, 33(1):12-16.
12. Zoll P.M., Wessler S., Schlesinger M.J. Interarterial coronary anastomoses in the human heart, with particular reference to anemia and relative cardiac anoxia. Circulation 1951, 4(6):797.
13. Van Belle E., Rivard A., Chen D., Silver M., Bunting S., Ferrara N., et al. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 1997, 96(8):2667.
14. Kornowski R. Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron Artery Dis 2003, 14(1):61.
15. Kyriakides Z.S., Kremastinos D.T., Michelakakis N.A., Matsakas E.P., Demovelis T., Toutouzas P.K. Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol 1991, 67(8):687-690.
16. Karpanou E.A., Vyssoulis G.P., Skoumas J.N., Zervopoulos G.A., Moundaki V.S., Toutouzas P.K. Significance of arterial hypertension on coronary collateral circulation development and left ventricular function in coronary artery disease. J Hypertens Suppl 1988, 6(4):S151.
17. Simons M., Bonow R.O., Chronos N.A., Cohen D.J., Giordano F.J., Hammond H.K., et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 2000, 102(11):e73.
18. Miosge N., Sasaki T., Timpl R. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. FASEB J 1999, 13(13):1743.
19. Semenza G.L. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor. J Clin Invest 2000, 106(7):809-812.
20. Schultz A., Lavie L., Hochberg I., Beyar R., Stone T., Skorecki K., et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999, 100(5):547.
21. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 2001, 13(2):167-171.
22. Tanimoto K., Yoshiga K., Eguchi H., Kaneyasu M., Ukon K., Kumazaki T., et al. Hypoxia-inducible factor-1 polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 2003, 24(11):1779.
23. Shohet R.V., Garcia J.A. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia. J Mol Med 2007, 85(12):1309-1315.
24. Rey S., Semenza G.L. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 2010, 86(2):236.
25. Ozaki H., Yu A.Y., Della N., Ozaki K., Luna J.D., Yamada H., et al. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 1999, 40(1):182.
26. Semenza G.L. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002, 64(5-6):993-998.
27. Chen C.H., Cartwright J., Li Z., Lou S., Nguyen H.H., Gotto A.M., et al. Inhibitory effects of hypercholesterolemia and ox-LDL on angiogenesis-like endothelial growth in rabbit aortic explants: essential role of basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 1997, 17(7):1303.
28. Clifford S.C., Astuti D., Hooper L., Maxwell P.H., Ratcliffe P.J., Maher E.R. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene 2001, 20(36):5067.
29. Kelly B.D., Hackett S.F., Hirota K., Oshima Y., Cai Z., Berg-Dixon S., et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003, 93(11):1074.
30. Rentrop K.P., Cohen M., Blanke H., Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985, 5(3):587.
31. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51(3):606.
32. Anvari M.S., Boroumand M.A. Aortic and mitral valve atherosclerosis: predictive factors and associations with coronary atherosclerosis using Gensini score. Arch Med Res 2009, 40(2):124-127.
33. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16(3):1215.
34. Resar J.R., Roguin A., Voner J., Nasir K., Hennebry T.A., Miller J.M., et al. Hypoxia-inducible factor 1 polymorphism and coronary collaterals in patients with ischemic heart disease. Chest 2005, 128(2):787.
35. Arthur W.T., Vernon R.B., Sage E.H., Reed M.J. Growth factors reverse the impaired sprouting of microvessels from aged mice. Microvasc Res 1998, 55(3):260-270.
36. Buschmann I., Schaper W. The pathophysiology of the collateral circulation (arteriogenesis). J Pathol 2000, 190(3):338-342.
37. Resnick N., Einav S., Chen-Konak L., Zilberman M., Yahav H., Shay-Salit A. Hemodynamic forces as a stimulus for arteriogenesis. Endothelium 2003, 10(4):197-206.
38. Simons M. Angiogenesis: where do we stand now?. Circulation 2005, 111(12):1556.
39. Schaper W. Collateral circulation. Basic Res Cardiol 2009, 104(1):5-21.
40. van Royen N., Piek J.J., Buschmann I., Hoefer I., Voskuil M., Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 2001, 49(3):543.